aspirin has been researched along with Hemorrhage, Retinal in 20 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess whether the use of aspirin exacerbates the severity or duration of vitreous/preretinal hemorrhages in patients with diabetic retinopathy." | 9.08 | Effects of aspirin on vitreous/preretinal hemorrhage in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report no. 20. ( Chew, EY; Ferris, FL; Klein, ML; Murphy, RP; Remaley, NA, 1995) |
| "Aspirin was not significantly associated with bleeding complications during or after surgery (p = 0." | 5.42 | A case-control study to assess aspirin as a risk factor of bleeding in rhegmatogenous retinal detachment surgery. ( Albaladejo, P; Aptel, F; Bernheim, D; Brillat, E; Chiquet, C; Palombi, K; Quesada, JL; Romanet, JP; Rouberol, F, 2015) |
| "To assess whether the use of aspirin exacerbates the severity or duration of vitreous/preretinal hemorrhages in patients with diabetic retinopathy." | 5.08 | Effects of aspirin on vitreous/preretinal hemorrhage in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report no. 20. ( Chew, EY; Ferris, FL; Klein, ML; Murphy, RP; Remaley, NA, 1995) |
| "We therefore examined the rate of all perioperative hemorrhages and separately the rate of only severe bleedings during vitrectomy, scleral buckling with or without drainage of subretinal fluid (SRD), or combined procedures due to retinal detachment in patients undergoing different types of perioperative anticoagulation including acetylsalicylic acetate (ASA), clopidogrel, heparin, low molecular weight heparin, and phenprocoumon." | 3.96 | Risk of perioperative bleeding complications in rhegmatogenous retinal detachment surgery: a retrospective single-center study. ( Affeldt, J; Bemme, S; Bertelmann, T; Callizo, J; Feltgen, N; Hoerauf, H; Khattab, MH; Lauermann, P; Pfeiffer, S; Striebe, NA, 2020) |
| "Most retinal or subretinal hemorrhages in eyes enrolled in CATT were less than 1 DA." | 2.82 | Association between Antiplatelet or Anticoagulant Drugs and Retinal or Subretinal Hemorrhage in the Comparison of Age-Related Macular Degeneration Treatments Trials. ( Ahmed, O; Daniel, E; Grunwald, JE; Maguire, MG; Martin, DF; Ying, GS, 2016) |
| "In the Early Treatment Diabetic Retinopathy Study, a randomized clinical trial sponsored by the National Eye Institute, one eye of each patient was assigned to early photocoagulation and the other to deferral of photocoagulation (i." | 2.67 | Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group. ( , 1991) |
| "Aspirin was not significantly associated with bleeding complications during or after surgery (p = 0." | 1.42 | A case-control study to assess aspirin as a risk factor of bleeding in rhegmatogenous retinal detachment surgery. ( Albaladejo, P; Aptel, F; Bernheim, D; Brillat, E; Chiquet, C; Palombi, K; Quesada, JL; Romanet, JP; Rouberol, F, 2015) |
| "Aspirin was recommended to reduce the risk of future thromboses." | 1.32 | Antiphospholipid antibody syndrome in a six-year-old female patient. ( Hartnett, ME; Laposata, M; Van Cott, E, 2003) |
| "During follow-up 56 recurrences occurred, making a total of 110 episodes of vitreous haemorrhage in 79 eyes of 54 patients." | 1.32 | Does cardiovascular therapy affect the onset and recurrence of preretinal and vitreous haemorrhage in diabetic eye disease? ( Banerjee, S; Denniston, AK; Dodson, PM; Gibson, JM, 2004) |
| "To report a case of Dengue fever resulting in permanent visual loss in both eyes due to retinal capillary occlusion." | 1.32 | Ocular manifestations in Dengue fever. ( Campos, WR; de Moraes Figueiredo, LT; Oréfice, F; Siqueira, RC; Vitral, NP, 2004) |
| "Intraretinal hemorrhages in both eyes and a scotoma in the left eye were found." | 1.30 | High-altitude retinopathy. ( Kuba, GB; Lang, GE, 1997) |
| "A therapy-resistant angle closure glaucoma following displacement of the lens-iris diaphragm due to massive choroidal and subretinal hemorrhages has rarely been reported." | 1.30 | [Acute glaucoma caused by massive subretinal hemorrhage in age-related macular degeneration and disordered thrombocyte function]. ( Hesse, L; Poller, S, 1997) |
| " No results with Colfarit were noted in the branch vein thromboses, in fact bleeding recurred in almost every case in the fifth week, when Colfarit was given for longer than 4 weeks in the dosage of 3 times 0." | 1.26 | [Observations and results of photodocumentation of retinal thromboses treated with Colfarit (author's transl)]. ( Schlosshardt, H, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (20.00) | 18.7374 |
| 1990's | 5 (25.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bemme, S | 1 |
| Lauermann, P | 1 |
| Striebe, NA | 1 |
| Khattab, MH | 1 |
| Affeldt, J | 1 |
| Callizo, J | 1 |
| Bertelmann, T | 1 |
| Pfeiffer, S | 1 |
| Hoerauf, H | 1 |
| Feltgen, N | 1 |
| Arruti, M | 1 |
| Aldazabal, M | 1 |
| Blanco, A | 1 |
| Piñeiro, L | 1 |
| Zapico, MS | 1 |
| González, F | 1 |
| López de Munain, A | 1 |
| Maalej, A | 1 |
| Khallouli, A | 1 |
| Loukil, M | 1 |
| Bellassoued, O | 1 |
| Rannen, R | 1 |
| Brillat, E | 1 |
| Rouberol, F | 1 |
| Palombi, K | 1 |
| Quesada, JL | 1 |
| Bernheim, D | 1 |
| Albaladejo, P | 1 |
| Aptel, F | 1 |
| Romanet, JP | 2 |
| Chiquet, C | 2 |
| Ying, GS | 1 |
| Maguire, MG | 1 |
| Daniel, E | 1 |
| Grunwald, JE | 1 |
| Ahmed, O | 1 |
| Martin, DF | 1 |
| Renard, E | 1 |
| Bouillet, L | 1 |
| Hayreh, SS | 1 |
| Podhajsky, PA | 1 |
| Zimmerman, MB | 1 |
| Hartnett, ME | 1 |
| Laposata, M | 1 |
| Van Cott, E | 1 |
| Banerjee, S | 1 |
| Denniston, AK | 1 |
| Gibson, JM | 1 |
| Dodson, PM | 1 |
| Soares, AS | 1 |
| Artes, PH | 1 |
| Andreou, P | 1 |
| Leblanc, RP | 1 |
| Chauhan, BC | 1 |
| Nicolela, MT | 1 |
| Siqueira, RC | 1 |
| Vitral, NP | 1 |
| Campos, WR | 1 |
| Oréfice, F | 1 |
| de Moraes Figueiredo, LT | 1 |
| Chew, EY | 1 |
| Klein, ML | 1 |
| Murphy, RP | 1 |
| Remaley, NA | 1 |
| Ferris, FL | 1 |
| Dapling, RB | 1 |
| Snowden, JA | 1 |
| West, J | 1 |
| Talbot, JF | 1 |
| Nelson, ME | 1 |
| Greaves, M | 1 |
| Lang, GE | 1 |
| Kuba, GB | 1 |
| Poller, S | 1 |
| Hesse, L | 1 |
| De Boer, B | 1 |
| Saari, M | 1 |
| Schlosshardt, H | 1 |
| Watillon, M | 1 |
| Robe-Vanwijck, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial (CATT)[NCT00593450] | Phase 3 | 1,208 participants (Actual) | Interventional | 2008-02-29 | Completed | ||
| [NCT00000151] | Phase 3 | 0 participants | Interventional | 1979-12-31 | Completed | ||
| Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Retinopathy for Subjects Who Completed the 2-Year PANORAMA Trial[NCT04708145] | Phase 4 | 150 participants (Anticipated) | Interventional | 2021-06-01 | Active, not recruiting | ||
| Early Laser Treatment for Diabetic Eye Disease in China: The PEARL Pilot Randomized Trial[NCT02956759] | 200 participants (Anticipated) | Interventional | 2016-10-31 | Recruiting | |||
| Prospective Study Phase: Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye[NCT01348672] | 381 participants (Anticipated) | Observational | 2012-03-31 | Recruiting | |||
| Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement[NCT03531294] | Phase 2 | 40 participants (Actual) | Interventional | 2018-05-23 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00593450)
Timeframe: at 1 Year
| Intervention | mm^2 (Mean) |
|---|---|
| 1-Lucentis Monthly | 6.6 |
| 2-Avastin Monthly | 6.5 |
| 3-Lucentis as Needed | 7.3 |
| 4-Avastin as Needed | 7.0 |
(NCT00593450)
Timeframe: Baseline and 1 Year
| Intervention | mm^2 (Mean) |
|---|---|
| 1-Lucentis Monthly | -0.1 |
| 2-Avastin Monthly | 0.3 |
| 3-Lucentis as Needed | 0.6 |
| 4-Avastin as Needed | 1.3 |
(NCT00593450)
Timeframe: at 1 Year
| Intervention | US dollars per patient (Mean) |
|---|---|
| 1-Lucentis Monthly | 23400 |
| 2-Avastin Monthly | 595 |
| 3-Lucentis as Needed | 13800 |
| 4-Avastin as Needed | 385 |
"Visual acuity testing was performed with the Electronic Visual Tester (EVA) following the ETDRS protocol. VA score is measured as number of letters read correctly. The VA score change is the difference of the VA score at 1 Year and the VA score at baseline.~In this study, the outcome VA score change is ranged from -71 to 52, with the higher VA score change the better visual acuity improvement." (NCT00593450)
Timeframe: Baseline and 1 Year
| Intervention | No. of Letters (Mean) |
|---|---|
| 1-Lucentis Monthly | 8.5 |
| 2-Avastin Monthly | 8.0 |
| 3-Lucentis as Needed | 6.8 |
| 4-Avastin as Needed | 5.9 |
(NCT00593450)
Timeframe: Baseline and 1 Year
| Intervention | mm Hg (Mean) |
|---|---|
| 1-Lucentis Monthly | -0.9 |
| 2-Avastin Monthly | -1.4 |
| 3-Lucentis as Needed | -1.9 |
| 4-Avastin as Needed | -2.1 |
(NCT00593450)
Timeframe: Baseline and 1 Year
| Intervention | mm Hg (Mean) |
|---|---|
| 1-Lucentis Monthly | -2.1 |
| 2-Avastin Monthly | -5.4 |
| 3-Lucentis as Needed | -5.2 |
| 4-Avastin as Needed | -4.5 |
Cumulative over the 1 year of trial (NCT00593450)
Timeframe: 1 Year
| Intervention | Number of Treatments (Mean) |
|---|---|
| 1-Lucentis Monthly | 11.7 |
| 2-Avastin Monthly | 11.9 |
| 3-Lucentis as Needed | 6.9 |
| 4-Avastin as Needed | 7.7 |
(NCT00593450)
Timeframe: at 1 Year
| Intervention | μm (Mean) |
|---|---|
| 1-Lucentis Monthly | 152 |
| 2-Avastin Monthly | 172 |
| 3-Lucentis as Needed | 166 |
| 4-Avastin as Needed | 172 |
(NCT00593450)
Timeframe: Baseline and 1 Year
| Intervention | μm (Mean) |
|---|---|
| 1-Lucentis Monthly | -100 |
| 2-Avastin Monthly | -79 |
| 3-Lucentis as Needed | -81 |
| 4-Avastin as Needed | -79 |
(NCT00593450)
Timeframe: at 1 Year
| Intervention | μm (Mean) |
|---|---|
| 1-Lucentis Monthly | 266 |
| 2-Avastin Monthly | 300 |
| 3-Lucentis as Needed | 294 |
| 4-Avastin as Needed | 308 |
(NCT00593450)
Timeframe: Baseline and 1 Year
| Intervention | μm (Mean) |
|---|---|
| 1-Lucentis Monthly | -196 |
| 2-Avastin Monthly | -164 |
| 3-Lucentis as Needed | -168 |
| 4-Avastin as Needed | -152 |
"Visual acuity testing was performed with the Electronic Visual Tester (EVA) following the ETDRS protocol. VA score is measured as number of letters read correctly.~In this study, the outcome VA score is ranged from 0 to 97, with the higher score the better visual acuity." (NCT00593450)
Timeframe: at 1 Year
| Intervention | No. of Letters (Mean) |
|---|---|
| 1-Lucentis Monthly | 68.8 |
| 2-Avastin Monthly | 68.4 |
| 3-Lucentis as Needed | 68.4 |
| 4-Avastin as Needed | 66.5 |
(NCT00593450)
Timeframe: Baseline and 1 Year
| Intervention | Participants (Number) | ||||
|---|---|---|---|---|---|
| Increase of ≥15 letters | Increase of 5-14 letters | Change of ≤4 letters | Decrease of 5-14 letters | Decrease of ≥15 letters | |
| 1-Lucentis Monthly | 97 | 90 | 62 | 19 | 16 |
| 2-Avastin Monthly | 83 | 98 | 50 | 18 | 16 |
| 3-Lucentis as Needed | 71 | 103 | 75 | 23 | 13 |
| 4-Avastin as Needed | 76 | 90 | 59 | 23 | 23 |
(NCT00593450)
Timeframe: at 1 Year
| Intervention | Participants (Number) | ||
|---|---|---|---|
| Absent | Present | Data missing | |
| 1-Lucentis Monthly | 167 | 97 | 20 |
| 2-Avastin Monthly | 153 | 100 | 12 |
| 3-Lucentis as Needed | 133 | 137 | 15 |
| 4-Avastin as Needed | 111 | 145 | 15 |
(NCT00593450)
Timeframe: at 1 Year
| Intervention | Participants (Number) | ||
|---|---|---|---|
| Absent | Present | Data missing | |
| 1-Lucentis Monthly | 124 | 151 | 9 |
| 2-Avastin Monthly | 69 | 188 | 8 |
| 3-Lucentis as Needed | 68 | 203 | 14 |
| 4-Avastin as Needed | 52 | 214 | 5 |
(NCT00593450)
Timeframe: at 1 Year
| Intervention | Participants (Number) | ||||
|---|---|---|---|---|---|
| 83-97 letters, 20/12-20 | 68-82 letters, 20/25-40 | 53-67 letters, 20/50-80 | 38-52 letters, 20/100-160 | ≤37 letters, ≤20/200 | |
| 1-Lucentis Monthly | 42 | 149 | 52 | 23 | 18 |
| 2-Avastin Monthly | 45 | 134 | 47 | 21 | 18 |
| 3-Lucentis as Needed | 38 | 141 | 66 | 23 | 17 |
| 4-Avastin as Needed | 40 | 127 | 57 | 24 | 23 |
1 review available for aspirin and Hemorrhage, Retinal
| Article | Year |
|---|---|
[Acute herpes simplex virus type 1 retinal necrosis three years after herpes simplex encephalitis].
Topics: Acyclovir; Antiviral Agents; Aspirin; Cataract Extraction; Causality; Drug Therapy, Combination; Enc | 2014 |
3 trials available for aspirin and Hemorrhage, Retinal
| Article | Year |
|---|---|
Association between Antiplatelet or Anticoagulant Drugs and Retinal or Subretinal Hemorrhage in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anticoagulants; Aspirin; Bevacizumab; Cardiovascul | 2016 |
Effects of aspirin on vitreous/preretinal hemorrhage in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report no. 20.
Topics: Adult; Aspirin; Diabetes Complications; Diabetic Retinopathy; Follow-Up Studies; Humans; Laser Coagu | 1995 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aneurysm; Aspirin; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus | 1991 |
16 other studies available for aspirin and Hemorrhage, Retinal
| Article | Year |
|---|---|
Risk of perioperative bleeding complications in rhegmatogenous retinal detachment surgery: a retrospective single-center study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Child; Child, Preschool; Clopid | 2020 |
[Post-contusive subfoveolar hematoma in a pregnant women taking aspegic].
Topics: Adult; Aspirin; Contusions; Eye Injuries; Female; Fovea Centralis; Hematoma; Humans; Lysine; Papille | 2015 |
A case-control study to assess aspirin as a risk factor of bleeding in rhegmatogenous retinal detachment surgery.
Topics: Aged; Aspirin; Case-Control Studies; Choroid Hemorrhage; Cryotherapy; Female; Humans; Intraoperative | 2015 |
[Frosted-branch angiitis revealing Behçet's disease].
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Behcet Syndrome; | 2009 |
Central and hemicentral retinal vein occlusion: role of anti-platelet aggregation agents and anticoagulants.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cohort Studies; Dipyridamole; F | 2011 |
Antiphospholipid antibody syndrome in a six-year-old female patient.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; | 2003 |
Does cardiovascular therapy affect the onset and recurrence of preretinal and vitreous haemorrhage in diabetic eye disease?
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiovascular Agents; Cardiovascula | 2004 |
Factors associated with optic disc hemorrhages in glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cohort Studies; Cyclooxygenase Inhibitors; Diabetes Complic | 2004 |
Ocular manifestations in Dengue fever.
Topics: Adult; Antibodies, Viral; Aspirin; Combined Modality Therapy; Dengue; Dengue Virus; Enzyme-Linked Im | 2004 |
The microvasculature in myeloproliferative disease. A study using retinal fluorescein angiography.
Topics: Adult; Aged; Aged, 80 and over; Allergens; Antineoplastic Agents; Arterial Occlusive Diseases; Aspir | 1996 |
High-altitude retinopathy.
Topics: Adult; Altitude Sickness; Aspirin; Blood Cell Count; Fluorescein Angiography; Fundus Oculi; Hematocr | 1997 |
[Acute glaucoma caused by massive subretinal hemorrhage in age-related macular degeneration and disordered thrombocyte function].
Topics: Acetaminophen; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Eye Enucleation; Female; Glau | 1997 |
New concepts in the clinical uses of aspirin: a review.
Topics: Aspirin; Cardiovascular System; Drug Interactions; Endocrine Glands; Humans; Platelet Aggregation; R | 1979 |
Disciform detachment of the macula. I. Juvenile haemorrhagic macular choroidopathy.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aspirin; Child; Choroid; Disseminated Intravascular Coag | 1977 |
[Observations and results of photodocumentation of retinal thromboses treated with Colfarit (author's transl)].
Topics: Aspirin; Fibrinolytic Agents; Follow-Up Studies; Fundus Oculi; Humans; Photography; Retinal Diseases | 1978 |
[Harmful effects of common drugs on the visual apparatus. Minor analgesics, antipyretics, nonsteroid anti-inflammatory and antirheumatic drugs].
Topics: Analgesics; Anti-Inflammatory Agents; Antimalarials; Aspirin; Color Vision Defects; Corneal Opacity; | 1972 |